Floatz logo

Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Silmitasertib
Liposarcoma
Milton S. Hershey Medical CenterP1/2CC (47)
Sirolimus
Frontotemporal Dementia
Prevail TherapeuticsP1/2CC (47)
Sirolimus
Skin Basal Cell Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
SL-28
Head And Neck Cancer
Second Life TherapeuticsP1/2CC (47)
SL-28
Malignant Pancreatic Neoplasm
Second Life TherapeuticsP1/2CC (47)
SLC391
Lung Carcinoma
SignalChem Lifesciences CorporationP1/2CC (47)
Solnerstotug
Cervical Cancer
Sensei Biotherapeutics, Inc.P1/2CC (47)
Solnerstotug
Uterine Cancer
Sensei Biotherapeutics, Inc.P1/2CC (47)
Sonrotoclax
B-Cell Neoplasm
BeOne MedicinesP1/2CC (47)
Sonrotoclax
Myelodysplastic/Myeloproliferative Neoplasm
BeiGeneP1/2CC (47)
Sotorasib
Malignant Pancreatic Neoplasm
Devalingam MahalingamP1/2CC (47)
st101
Melanoma
Sapience TherapeuticsP1/2CC (47)
st-503
Neuropathy, Painful
Sangamo TherapeuticsP1/2CC (47)
Star0602
Lung Neoplasm
Marengo Therapeutics, Inc.P1/2CC (47)
Star0602
Neoplasm
Marengo Therapeutics, Inc.P1/2CC (47)
Star0602
Urinary System Neoplasm
Marengo Therapeutics, Inc.P1/2CC (47)
Stc-15
Dedifferentiated Liposarcoma
STORM Therapeutics LTDP1/2CC (47)
Stc-15
Leiomyosarcoma
STORM Therapeutics LTDP1/2CC (47)
Sulfur Hexafluoride
Glioblastoma
University of CincinnatiP1/2CC (47)
Sulfur Hexafluoride
Nervous System Neoplasm
NaviFUS CorporationP1/2CC (47)
Sumarotene
Metastatic Prostate Carcinoma
CuraCell TX ABP1/2CC (47)
Supcd7 Cart Cells
T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1/2CC (47)
Surovatamig
B-Cell Chronic Lymphocytic Leukemia
AstraZenecaP1/2CC (47)
svg103
Tuberous Sclerosis
SovargenP1/2CC (47)
SX682
Adenoid Cystic Carcinoma
National Cancer Institute (NCI)P1/2CC (47)
Showing 2626 to 2650 of 6,305 assets
PreviousPage 106 of 253Next